TY - JOUR
T1 - MyD88-dependent induction of allergic Th2 responses to intranasal antigen
AU - Piggott, Damani A.
AU - Eisenbarth, Stephanie C.
AU - Xu, Lan
AU - Constant, Stephanie L.
AU - Huleatt, James W.
AU - Herrick, Christina A.
AU - Bottomly, Kim
PY - 2005/2
Y1 - 2005/2
N2 - MyD88 is a common Toll-like receptor (TLR) adaptor molecule found to be essential for induction of adaptive Th1 immunity. Conversely, innate control of adaptive Th2 immunity has been shown to occur in a MyD88-independent manner. In this study, we show that MyD88 is an essential innate component in the induction of TLR4-dependent Th2 responses to intranasal antigen; thus we demonstrate what we believe to be a novel role for MyD88 in pulmonary Th2 immunity. Induction of the MyD88-independent type I IFN response to LPS is defective in the pulmonary environment. Moreover, in the absence of MyD88, LPS-induced upregulation of costimulatory molecule expression on pulmonary DCs is defective, in contrast to what has been observed with bone marrow-derived DCs (BMDCs). Reconstitution of Th2 responses occurs upon adoptive pulmonary transfer of activated BMDCs to MyD88-deficient recipients. Furthermore, the dependence of Th2 responses on MyD88 is governed by the initial route of antigen exposure; this demonstrates what we believe are novel site-specific innate mechanisms for control of adaptive Th2 immunity.
AB - MyD88 is a common Toll-like receptor (TLR) adaptor molecule found to be essential for induction of adaptive Th1 immunity. Conversely, innate control of adaptive Th2 immunity has been shown to occur in a MyD88-independent manner. In this study, we show that MyD88 is an essential innate component in the induction of TLR4-dependent Th2 responses to intranasal antigen; thus we demonstrate what we believe to be a novel role for MyD88 in pulmonary Th2 immunity. Induction of the MyD88-independent type I IFN response to LPS is defective in the pulmonary environment. Moreover, in the absence of MyD88, LPS-induced upregulation of costimulatory molecule expression on pulmonary DCs is defective, in contrast to what has been observed with bone marrow-derived DCs (BMDCs). Reconstitution of Th2 responses occurs upon adoptive pulmonary transfer of activated BMDCs to MyD88-deficient recipients. Furthermore, the dependence of Th2 responses on MyD88 is governed by the initial route of antigen exposure; this demonstrates what we believe are novel site-specific innate mechanisms for control of adaptive Th2 immunity.
UR - http://www.scopus.com/inward/record.url?scp=14944375918&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14944375918&partnerID=8YFLogxK
U2 - 10.1172/JCI200522462
DO - 10.1172/JCI200522462
M3 - Article
C2 - 15650773
AN - SCOPUS:14944375918
SN - 0021-9738
VL - 115
SP - 459
EP - 467
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 2
ER -